backed by Combinator

Lattice

Spatial proteomics from H&E

Lattice predicts spatially resolved protein-marker maps from routine H&E, delivered as virtual multiplex immunofluorescence (mIF) channels. No new assay, no new hardware, and no tissue consumed.

Run it on your slides
Loading interactive slide...
A live Lattice prediction on a public TCGA colorectal H&E. Drag to pan, scroll to zoom, toggle predicted protein channels. No sign-in.

One slide in. A stack of protein maps out.

Lattice takes a standard H&E image and predicts spatially resolved protein expression across a broad panel of immune, structural and functional markers. The output sits at the resolution of the underlying image, so you can work at whole-slide scale or zoom to individual cells.

Pan-cancer

Built across a wide span of tumour and tissue types rather than a single indication with a fixed marker panel.

Cohort scale

Runs across an entire archive, so a retrospective study is a compute question rather than a tissue question.

Tunable to you

Fine-tunes to your indications and your target panel when the question is specific enough to need it.

The tissue is the bottleneck.

Multiplex immunofluorescence is expensive, slow, and consumes the sample. Biopsy requirements in trials keep tightening, most archival material is scarce or exhausted, and re-acquisition is usually impossible. So the spatial layer that would answer the question is missing from almost every cohort that matters.

H&E is the one thing everybody already has. Lattice predicts spatial protein maps from it, which puts decades of shelved slides back in play.

Delivered as a service, not as homework.

We run Lattice end to end. Your team sends slides and gets answers, with nothing to install, validate or staff.

  1. 01

    Send H&E

    Digitised slides from a trial cohort or an archive, with whatever clinical annotation you can share.

  2. 02

    We run and analyse

    Predicted spatial proteomics across the cohort, then segmentation, phenotyping and the spatial analysis on top of it.

  3. 03

    Get a decision-ready readout

    Structured spatial data plus a written analysis aimed at the biomarker question you actually asked.

For cohorts that cannot leave your institution, we deploy and run Lattice entirely within your environment.

Where teams point it

Target screening

Look at target expression and its spatial context across cohorts where the assay was never run.

Patient stratification

Group a cohort by spatial phenotype and see how the tumour microenvironment differs between the groups.

Retrospective rescue

Profile archives that were never intended for spatial work, without consuming a single section.

Wet-lab triage

Decide which samples justify the cost of real multiplex work instead of guessing at the shortlist.

Custom model partnerships

Your question should define the panel.

When the standard Lattice panel does not cover the biology you need, we can scope a custom model partnership around a target or marker panel of interest. For biopharma and diagnostics teams, we start with the scientific question, your cohort, and the H&E you already have.

Scoped to your study

We define the target, indication, cohort, training material, and validation plan together before development begins.

One team through the readout

Strand handles custom development, cohort-scale prediction, spatial analysis, and a written readout as one end-to-end project.

Tell us the target or panel, the cohort, and the decision the study needs to support. We will assess whether a custom Lattice project is a fit.

Research use only (RUO). Not for use in clinical or diagnostic procedures.